Literature DB >> 1721817

The control of homologous lysis.

P J Lachmann1.   

Abstract

Complement activation unleashes powerful effector mechanisms against which host cells are protected by homologous restriction factors. These factors are glycolipid-anchored membrane proteins that either induce C3 convertase dissociation (for example decay-accelerating factor) or prevent the full development of the membrane attack complex (for example homologous restriction factor and CD59). In this article Peter Lachmann explores the biology and biochemistry of these important and intriguing molecules.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1721817     DOI: 10.1016/0167-5699(91)90005-E

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  36 in total

Review 1.  Complement deficiency.

Authors:  K M O'Neil
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

Review 2.  Modulation of complement membrane attack by local C7 synthesis.

Authors:  R Würzner
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

3.  Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction.

Authors:  T Tada; H Okada; N Okada; H Tateyama; H Suzuki; Y Takahashi; T Eimoto
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

4.  The serum resistance of malaria-infected erythrocytes.

Authors:  Y Kawamoto; K Kojima; Y Hitsumoto; H Okada; V M Holers; A Miyama
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

5.  Deficiency in mouse hyaluronidase 2: a new mechanism of chronic thrombotic microangiopathy.

Authors:  Cécile Onclinx; Sophie Dogne; Laurence Jadin; Fabienne Andris; Christian Grandfils; François Jouret; François Mullier; Bruno Flamion
Journal:  Haematologica       Date:  2015-05-01       Impact factor: 9.941

6.  Imaging bioluminescent indicators shows Ca2+ and ATP permeability thresholds in live cells attacked by complement.

Authors:  G B Sala-Newby; K M Taylor; M N Badminton; C M Rembold; A K Campbell
Journal:  Immunology       Date:  1998-04       Impact factor: 7.397

7.  Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract.

Authors:  A E Berstad; P Brandtzaeg
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

8.  Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.

Authors:  S Varsano; L Rashkovsky; H Shapiro; D Ophir; T Mark-Bentankur
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

9.  The sheep analogue of human CD59: purification and characterization of its complement inhibitory activity.

Authors:  C W van den Berg; R A Harrison; B P Morgan
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

10.  Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59.

Authors:  J Schmitz; J P Zimmer; B Kluxen; S Aries; M Bögel; I Gigli; H Schmitz
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.